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1 (The late).A case report of a right ventricular mass in a
patient with Behc¸et’s disease: Myxoma or thrombus?
M.A. Ghori a,⇑, Awatif Al Sousi a,1, Wael Al Mahmeed a, Samer Ellahham a,
Moataz Ayman b, Norbert Augustin b
a Department of Cardiac Sciences, Adult Cardiology Department, Sheikh Khalifa Medical City; b Department of Cardiac Sciences,
Cardiac Surgery Department, Sheikh Khalifa Medical City
a–bAbu DhabiIntroduction: Behc¸et’s disease (BD) is a multi-system, chronic and relapsing disorder classified as ‘‘vasculitic
syndrome’’. It typically affects young adult females between 20 and 40 years of age. There are some typical clinical
manifestations associated with this disease, however, at times; rare sign and symptoms pose a challenge to the treating
physician and making a definitive diagnosis. Presentations with cardiac symptoms are one of the extremely rare
manifestations of the Behc¸et’s disease.
Methods: The authors present clinical, laboratory and imaging findings of a patient who presented with a cardiac
mass which was the first presenting feature or manifestation of Behc¸et’s disease.
Results: A 19-year-old boy was admitted to our hospital for the investigation of ‘‘fever of unknown origin’’, weight
loss, shortness of breath and a scrotal ulcer of recent on-set. X-ray chest and electrocardiograms were inconclusive.
Transthoracic echocardiography revealed a right ventricular (RV) mass attached to the interventricular septum mea-
suring 1.5  1.5 cms (Panel A). Cardiac MRI identified it as a RV Myxoma. In addition, on CT scan of the chest pul-
monary embolism was noted. The patient underwent excision biopsy of the tumor under cardiopulmonary bypass via
right atriotomy (Panel B). Histopathology of the mass described it as ‘‘an organizing thrombus with a few groups of
interrupted myocardial fibers and some infiltration of lymphocytes and plasma cells’’. Moreover his HLA typing was
found positive for HLA-B51 (5). In view of the above findings and associated lesions, the patient was diagnosed as a
case of Behc¸et’s disease. The medical management included immunosuppressant and anticoagulation.
Conclusion: Behc¸et’s disease, even in the absence of the typical clinical features, should be considered in the dif-
ferential diagnosis of right ventricular mass, especially when dealing with young adults from the Mediterranean
basin and the Middle-East.
 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
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Behçet’s disease (BD) is a multisystem, chronic,relapsing condition classified as an auto-
inflammatory syndrome, sharing some common1016–7315  2012 King Saud University.
Production and hosting by Elsevier B.V. All rights reserved.
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http://dx.doi.org/10.1016/j.jsha.2013.02.001immune and genetic mechanisms [1,2]. Despite
its common manifestations, presentations with
cardiac symptoms are one of the rare manifesta-
tions of BD, posing a challenge for the treating
physician. During the current era of highlyProduction and hosting by Elsevier
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Echocardiography, Computed Tomography Scan
and Magnetic Resonant Imaging (MRI), more
and more reports on cardiovascular involvement,
predominantly related to right-sided heart, have
been published [3–11]. The authors are reporting
this case to highlight this relatively rare presenta-
tion of BD which might be of interest for physi-
cians and surgeons.Figure 1. Echocardiographic view of the mass in right ventricle.
Figure 2. Macroscopic view of the excised mass.Case history
A 19-year-old Jordanian male was referred to an
out-unit for the surgical removal of an RV mass.
The gentleman had a history of weight loss and fe-
ver over two months and a remote past history of
recurrent oral ulcers. On physical examination,
the patient had a fever of 37.8 C, a right scrotal ul-
cer and multiple scattered indurations at the pre-
vious venipuncture points. The systemic
examination was otherwise unremarkable.
A repeat echocardiographic examination con-
firmed the presence of a 2.1  1.5 cm, rounded
mass of non-uniform echogenicity attached to the
right side of IVS (Fig. 1). A Doppler ultrasonograph-
ic scan of both lower limbs was negative for deep
vein thrombosis and a pulmonary ventilation/per-
fusion scan showed a mismatched, peripheral
wedge-shaped perfusion abnormality involving
part of the superior segment of the right lower lobe
suggesting sub-segmental pulmonary infarction.
Cardiac MRI reported it as a well-defined, round
shape, smooth, inhomogeneous and pedunculated
mass, arising from the interventricular septum and
protruding into the apical aspect of the RV. There
was partially increased signal intensity on the T2
weighted sequence and moderate enhancement
following gadolinium, the features favoring the
diagnosis of a RV myxoma. In context with the his-
tory of fever, the possibilities of an RV myxoma, in-
fected vegetation or an intracardiac metastatic
lesion were considered. Owing to the presence of
fever, scrotal ulcer and indurations at the previous
venipuncture points (Perthes’ response) and a past
history of recurrent oral ulcers, BD was also
thought as one of the primary diagnoses and the
RV mass could be a thrombus due to BD.
Considering the potential risk of mechanical
obstruction of the pulmonary valve by the mass,
its embolization to the pulmonary circulation with
fatal consequences, as well as, to have a histopa-
thological diagnosis, the patient underwent
surgical excision of the tumour. Macroscopically,
it was found to be an oval shaped mass, measuring
1.2  0.7  0.3 cm at its greatest dimension (Fig. 2).Histopathological examination revealed an
organizing thrombus with a few groups of inter-
rupted myocardial fibers and some infiltration of
lymphocytes and plasma cells (Fig. 3). Serological
profile was negative for antinuclear antibodies
and rheumatoid factor. Three sets of blood culture
did not show any growth. Human leukocyte anti-
gen analysis detected HLA-B, B51 (5). Aforemen-
tioned data collectively confirmed the diagnosis
of BD and RV thrombus as one of its rare presenta-
tions. The patient was put on heparin, warfarin,
corticosteroids and azathioprine and discharged
from hospital a week after the surgery. Follow up
TTE was cleared of RV mass (Fig. 4).Discussion
BD is a chronic inflammatory disorder with mul-
tisystemic manifestations. Cardiac involvement is
a rare occurrence and has ranged from 7% to
29% of reported cases [12]. In one series of analy-
Figure 3. Histopathological slide of the mass.
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patients with cardiac involvement [13].
BD has high prevalence in Japan and eastern
Mediterranean countries and is relatively low in
United States and Northern Europe. It is most com-
mon in Turkey (80–370 cases per 100,000) [14]. It typ-
ically affects young adults between 20 and 40 years
of age and females are outnumbered by males.
To date, no specific etiological agent responsible
for this disorder has been identified. Clinical,
immunological and genetic features of BD led to
its classification within the frames of systemic vas-
culitides, seronegative spondyloarthritides and,
more recently, auto-inflammatory disorders [1,15].
Conventionally, the syndrome is diagnosed by
the symptoms of recurrent oral ulcers, genital ul-
cers, uveitis, arthritis, skin lesions and nervous
system involvement. The Behçet’s Disease Com-
mittee of Japan and International Study Group
for Behçet’s Disease have proposed major and
minor criteria [16,17]. Both, however, lack theFigure 4. Echocardiographic apical four chamber view afappreciation of cardiac involvement in BD which
might manifest as pericarditis, cardiomyopathy,
myocarditis, endocarditis, valvular dysfunction,
endomyocardial fibrosis, conduction abnormali-
ties, coronary artery disease, pseudo-aneurysm,
rupture of the sinus of Valsalva and intracardiac
thrombus [18–20].
The exact pathological mechanism of cardiac
thrombus formation in BD is unknown. In most
cases, the histological description of the thrombus
and underlying myocardium suggests an inflam-
matory process with dominantly mononuclear cell
infiltrate. On the other hand, in some cases,
biopsy findings included endomyocardial fibrosis
or normal myocardium. A high level of erythro-
cyte sedimentation rate, C-reactive proteins, anti-
phospholipid antibodies, anti-endothelial
antibodies, von Willebrand factor and plasma
endothelin-I level support an auto-immune and
inflammatory theory.
In BD, the site of the intracardiac thrombus is
variable. In an analysis of 25 patients, more than
half were found to have thrombus in RV (52%).
RA was the second most commonly involved cav-
ity (24%). Left atrium and left ventricle were the
least affected chambers (4% each) and multi-
chamber thrombi were found in 16% of the sub-
jects [21]. It is unclear why the thrombi in BD have
an increased propensity for right-sided chambers.
Although surgical exploration and autopsy find-
ings suggest that the thrombus is tightly attached
to the underlying myocardium, it is still considered
a potential source of distal embolization, particu-
larly to the lungs resulting in pulmonary embolism
and infarction as was found on the pulmonary ven-
tilation/perfusion scan in our patient. Moreover,
the physical presence of the thrombus may cause
valvular and atrioventricular dysfunction, result-
ing in symptoms of right-sided heart failure.ter the excision of the mass from the right ventricule.
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prognosis and mortality can be as high as 20% in
the months or years following diagnosis [22]. The
primary goal of management is immunosuppres-
sion and immunomodulation. Uncertainties
surround the issue of anticoagulation as no
controlled data exists on the benefits of anticoagu-
lants in the management of cardiac thrombi in BD.
Recently released guidelines for the management
of BD [23] do not discuss the use of warfarin, spe-
cifically in reference to intracardiac thrombus in
this condition. Nevertheless, a substantial number
of case reports have been published wherein vita-
min-K antagonist has been effectively used
[24,5,25]. Our patient was treated successfully with
azathioprine, steroids, and warfarin. Reservations
about the use of anticoagulation in BD remain [26]
and further studies are warranted to provide the
clinician with recommendations over the safety
and effectiveness of anticoagulation in cardiac
BD. Cardiac surgeons may be involved in certain
potentially life-threatening associations such as
in the index case.Conclusion
The authors believe that in the presence of con-
stitutional symptoms, BD should be considered in
the differential diagnosis of the right ventricular
mass, especially when dealing with young adults
from the Mediterranean basin and the Middle
East. The initial diagnosis of cardiovascular BD
can be extremely difficult, especially in the ab-
sence of its florid clinical manifestations. On occa-
sion, cardiac symptoms may be the presenting
complaints and may precede other signs and
symptoms essential for the diagnosis of this dis-
ease by many years. Thus upon finding an intra-
cardiac mass, with a history of weight loss, fever
and other non-specific symptoms, BD should be
considered as one of the possibilities in addition
to more commonly known conditions like myx-
oma and vegetation. Familiarity with this rare car-
diac condition might help in early diagnosis and
treatment of BD.Competing interest
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